Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults
Bardet-Biedl Syndrome: Clinical and Genetic Epidemiology Study in the Adults
1 other identifier
observational
40
1 country
1
Brief Summary
This study is based on the study of the natural history of a rare disorder: the Bardet-Biedl syndrome (BBS) (which is associated with retinitis pigmentosa, polydactyly, cognitive impairment, obesity, and kidney failure). The clinical, biological, and radiological features of adult patients are studied. In parallel, a molecular study is performed on the known genes to date (8 genes from BBS1 to BBS8) and to identify new genes involved. The parts of the study are combined in a phenotype-genotype correlation study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 21, 2005
CompletedAugust 8, 2008
August 1, 2008
September 13, 2005
August 7, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Outcome evaluated end 2005 and 2006
Clinical results (natural history, phenotype-genotype correlations, genetic epidemiology, new genes identification
Secondary Outcomes (1)
This study may lead to further clinical investigations according to the results (new protocol to be established) and to further molecular investigations
Interventions
Eligibility Criteria
You may qualify if:
- Adult (age over 16 years old)
- At least 3 of the five major criteria (retinitis pigmentosa, obesity, polydactyly, cognitive impairment, and kidney disorder) and/or BBS mutations identified
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hélène Dollfus
Strasbourg, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hélène Dollfus, MD
Fédération Génétique
- PRINCIPAL INVESTIGATOR
J-Louis Mandel, MD
IGBMC
- PRINCIPAL INVESTIGATOR
Pascal Bousquet, MD
CIC Strasbourg
- PRINCIPAL INVESTIGATOR
Christian Brandt, MD
CIC Strasbourg
- PRINCIPAL INVESTIGATOR
Catherine Arnold, MD
CIC Strasbourg
- PRINCIPAL INVESTIGATOR
Alain Verloes, MD
Unité de Génétique Robert Debré
- PRINCIPAL INVESTIGATOR
Régis Hanfard, MD
CIC Robet Debré
- PRINCIPAL INVESTIGATOR
Didier Lacombe, MD
Service de Génétique Médicale/Bordeaux
- PRINCIPAL INVESTIGATOR
Virginie Bernard, MD
CIC Bordeaux
- PRINCIPAL INVESTIGATOR
Sylvie Manouvrier, MD
Service de Génétique Médicale Lille
Study Design
- Study Type
- observational
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 21, 2005
Study Start
June 1, 2003
Last Updated
August 8, 2008
Record last verified: 2008-08